162 related articles for article (PubMed ID: 32414956)
1. Infections Are Associated With Increased Risk of Giant Cell Arteritis: A Population-based Case-control Study from Southern Sweden.
Stamatis P; Turkiewicz A; Englund M; Jönsson G; Nilsson JÅ; Turesson C; Mohammad AJ
J Rheumatol; 2021 Feb; 48(2):251-257. PubMed ID: 32414956
[TBL] [Abstract][Full Text] [Related]
2. Rate of Comorbidities in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Englund M; Turesson C; Tomasson G; Merkel PA
J Rheumatol; 2017 Jan; 44(1):84-90. PubMed ID: 27803140
[TBL] [Abstract][Full Text] [Related]
3. Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden.
Stamatis P; Mohammad MA; Gisslander K; Merkel PA; Englund M; Turesson C; Erlinge D; Mohammad AJ
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38599652
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden-an update on incidence and first prevalence estimate.
Stamatis P; Turkiewicz A; Englund M; Turesson C; Mohammad AJ
Rheumatology (Oxford); 2021 Dec; 61(1):146-153. PubMed ID: 33742665
[TBL] [Abstract][Full Text] [Related]
5. Malignancies in Giant Cell Arteritis: A Population-based Cohort Study.
Stamatis P; Turesson C; Willim M; Nilsson JÅ; Englund M; Mohammad AJ
J Rheumatol; 2020 Mar; 47(3):400-406. PubMed ID: 31154410
[TBL] [Abstract][Full Text] [Related]
6. Incidence of infections in patients with giant cell arteritis: a cohort study.
Durand M; Thomas SL
Arthritis Care Res (Hoboken); 2012 Apr; 64(4):581-8. PubMed ID: 22184094
[TBL] [Abstract][Full Text] [Related]
7. Infections and the risk of incident giant cell arteritis: a population-based, case-control study.
Rhee RL; Grayson PC; Merkel PA; Tomasson G
Ann Rheum Dis; 2017 Jun; 76(6):1031-1035. PubMed ID: 27895041
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis: a population-based case-control study.
Turkiewicz A; Stamatis P; Mohammad AJ
RMD Open; 2020 Aug; 6(2):. PubMed ID: 32792416
[TBL] [Abstract][Full Text] [Related]
9. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden.
Mohammad AJ; Nilsson JÅ; Jacobsson LT; Merkel PA; Turesson C
Ann Rheum Dis; 2015 Jun; 74(6):993-7. PubMed ID: 24442881
[TBL] [Abstract][Full Text] [Related]
10. Hospitalized infections in giant cell arteritis: a population-based retrospective cohort study.
Udayakumar PD; Chandran AK; Crowson CS; Warrington KJ; Matteson EL
J Rheumatol; 2014 Dec; 41(12):2447-51. PubMed ID: 25320223
[TBL] [Abstract][Full Text] [Related]
11. Visual Complications in Patients with Biopsy-proven Giant Cell Arteritis: A Population-based Study.
Saleh M; Turesson C; Englund M; Merkel PA; Mohammad AJ
J Rheumatol; 2016 Aug; 43(8):1559-65. PubMed ID: 27252424
[TBL] [Abstract][Full Text] [Related]
12. The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study.
Dar L; Ben-Shabat N; Tiosano S; Watad A; McGonagle D; Komaneshter D; Cohen A; Bragazzi NL; Amital H
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300046
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study.
Schmidt J; Smail A; Roche B; Gay P; Salle V; Pellet H; Duhaut P
Arthritis Rheumatol; 2016 Jun; 68(6):1477-82. PubMed ID: 26815885
[TBL] [Abstract][Full Text] [Related]
14. Risk of Cancer in 767 Patients with Giant Cell Arteritis in Western Norway: A Retrospective Cohort with Matched Controls.
Brekke LK; Fevang BS; Diamantopoulos AP; Assmus J; Esperø E; Gjesdal CG
J Rheumatol; 2020 May; 47(5):722-729. PubMed ID: 31308209
[TBL] [Abstract][Full Text] [Related]
15. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Diamantopoulos AP; Fevang BT; Aβmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2017 Dec; 19(1):278. PubMed ID: 29246164
[TBL] [Abstract][Full Text] [Related]
16. Trajectory of Healthcare Resource Utilization in Giant Cell Arteritis: A Population-based Study.
Mohammad AJ; Turkiewicz A; Stamatis P; Turesson C; Englund M; Kiadaliri A
J Rheumatol; 2021 Aug; 48(8):1307-1313. PubMed ID: 33649063
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and the risk of giant cell arteritis: results from a prospective study.
Jakobsson K; Jacobsson L; Warrington K; Matteson EL; Liang K; Melander O; Turesson C
Rheumatology (Oxford); 2015 Mar; 54(3):433-40. PubMed ID: 25193806
[TBL] [Abstract][Full Text] [Related]
18. Cancer preceding giant cell arteritis: a case-control study.
Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Ytterberg SR; Matteson EL; Gabriel SE; Warrington KJ
Arthritis Rheum; 2010 Jun; 62(6):1763-9. PubMed ID: 20191583
[TBL] [Abstract][Full Text] [Related]
19. Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study.
Elfishawi M; Rakholiya J; Gunderson TM; Achenbach SJ; Crowson CS; Matteson EL; Turesson C; Wadström K; Weyand C; Koster MJ; Warrington KJ
J Rheumatol; 2023 Apr; 50(4):526-531. PubMed ID: 36521923
[TBL] [Abstract][Full Text] [Related]
20. Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.
Catanoso M; Macchioni P; Boiardi L; Muratore F; Restuccia G; Cavazza A; Pipitone N; Mancuso P; Luberto F; Salvarani C
Arthritis Care Res (Hoboken); 2017 Mar; 69(3):430-438. PubMed ID: 27214746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
